Medical Research
(H20)
THE AMERICAN SOCIETY OF GENE & CELL THERAPY
CharityAI™ Score
Not yet evaluated
Financial Overview — FY 2023
$16.4M
Total Revenue
$13.8M
Total Expenses
N/A
Net Assets
45
Employees
Expense Breakdown
Program Expense Ratio
N/A
Fundraising Efficiency
N/A
Operating Reserve
N/A
Liability-to-Asset
N/A
Revenue Diversification
N/A
Executive Compensation
$469K
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2023 | $16.4M | $13.8M | N/A | — | 45 |
| 2022 | $12.5M | $11.0M | N/A | — | 40 |
| 2021 | $9.2M | $6.2M | N/A | — | 30 |
Donor Reviews
No reviews yet
Be the first to share your experience with this organization.